Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-14

FDA Approved: CYCLOSPORINE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Teva Pharmaceuticals' generic cyclosporine under an original application (ANDA 203880), expanding access to this immunosuppressant. The approval su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)

Snippet

ORIG AP for CYCLOSPORINE (CYCLOSPORINE)